The natriuretic and diuretic effects of a intravenous dose of torsemide administered as a continuous infusion of torsemide and as a single bolus were compared in a group of torsemide dosage with stable mild-to-moderate congestive heart failure CHF. torsemide dosage intravenous
Patients received in random order mg of torsemide as an intravenous bolus and as a mg infusion over 24 hours started simultaneously with a mg loading intravenous. Administration of torsemide to patients with CHF as a torsemide dosage intravenous infusion was an effective dosing torsemide dosage intravenous, resulting in hour diuresis and natriuresis that was numerically but not statistically greater torsemide dosage intravenous that observed with bolus administration.
The response with continuous infusion occurred with less torsemide in the urine, resulting in a significantly greater efficiency of torsemide dosage intravenous with this regimen. The effectiveness of torsemide as torsemide dosage intravenous continuous infusion does not mean that this mode of administration should be used in all patients.
The torsemide dosage intravenous to mg of torsemide torsemide dosage intravenous patients with mild-to-moderate CHF is the same whether administered as an intravenous bolus, intravenous continuous intravenous infusion, or by mouth.
This is consistent this web page the high bioavailability demonstrated in torsemide dosage intravenous studies. The mode of therapy used should be dictated by each individual patient's needs. This study shows that continuous infusion is a viable option for administration of torsemide, and dosing torsemide dosage intravenous for use of such a strategy are presented.
2018 ©